Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
57,753.51 +647.97 (+1.13%) CMC Crypto 200
1,266.21 -4.53 (-0.36%)
ABT Sep 2024 105.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:07PM EDT. Market open.
| Previous close | 3.9500 |
| Open | 3.9500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 105.00 |
| Expiry date | 2024-09-20 |
| Day's range | 3.9500 - 3.9600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.